Value Investing - Page 2

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

As the markets roll into summer, the markets are close to all-time highs and investors are wondering how they should be positioned as the bull market is now over eight ...
Read Full Story »

Can Protagonist Therapeutics Stock Still Double After Its Huge Gain?

Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just assumed this was a takeover or that the company had ...
Read Full Story »

Are Retail and Apparel Dividend Yields Reaching Panic Levels?

Investors love dividends. For long-term investors, dividends can account for more than half of total returns over time. While investors love companies with high dividend yields and those that can be ...
Read Full Story »

5 Stocks With Big Implied Upside and Limited Downside

The bull market entered its eighth year in 2017, and the Dow Jones Industrial Average and the S&P 500 have hit new all-time highs multiple times since the end of ...
Read Full Story »

Can Noble Energy Shares Rise Over 50%?

Merrill Lynch resumed coverage of Noble Energy Inc. (NYSE: NBL) with a Buy rating and assigned a $49 price objective on Tuesday. While the shares closed at $31.09 on Monday, ...
Read Full Story »

10 Stocks Analysts Want You to Sell

Now that the bull market is more than eight years old and many of the pro-growth policies out of Washington may be muted or delayed, many investors are wondering how they ...
Read Full Story »

Should Exxon Mobil Investors Expect 30% Upside in Returns?

When most analysts issue Buy and Outperform ratings on Dow Jones Industrial Average and S&P 500 stocks, the typical projected upside is 8% to 15% at this stage in the ...
Read Full Story »

Why Pandora Buyout Optimism May Already Be Cooling

Pandora Media Inc. (NYSE: P) might feel lucky after its earnings report. It is sometimes the case that internal workings and poor fundamentals of a company get overlooked because of ...
Read Full Story »

Is First Solar Getting Too Much Love From Analysts?

First Solar Inc. (NASDAQ: FSLR) was a winner in the days ahead of earnings, and Wednesday has proven to be a big post-earnings win for the leader of U.S. solar power. ...
Read Full Story »

Gilead Faces Serious Conundrum: Value Trap vs Real Value

Gilead Sciences Inc. (NASDAQ: GILD) had perhaps become the greatest biotech growth story of all time. In a world that only rewards what you will do next rather than what ...
Read Full Story »

How Much Staples Could Really Fetch in a Buyout

If you have followed the dust cloud of failed mergers over the years, chances are high that you know the saga of the failed merger between Staples, Inc. (NASDAQ: SPLS) ...
Read Full Story »

Value or Value Trap: Meet the 21 S&P 500 Stocks Valued Under 10 Times Earnings

The bull market is now well over eight years old, and investors are looking for new ideas for how they should be investing their money. Stocks, bonds and commodities are all ...
Read Full Story »

7 Speculative Analyst Stocks Called to Rise 100% or More

The bull market has raged on for more than eight years now, and the major stock market indexes are all up more than 200% from the V-bottom lows of 2009. Despite ...
Read Full Story »

Is AT&T the Best Defensive Stock Against a 2017 Market Correction?

Now that we basically are one-third of the way through 2017, one amazing trend is that this eight-year-old bull market continues to rage on. Despite a weaker-than-expected gross domestic product report ...
Read Full Story »

Why Credit Suisse Just Went Mega-Bullish on Cisco, With 3 Buyout Targets

Cisco Systems Inc. (NASDAQ: CSCO) is one of the top technology companies in the world. The company is a Dow Jones Industrial Average component and is one of the top ...
Read Full Story »